Xactagen focuses its genetic engineering expertise on combining highly successful, physiology-based drug discovery with disease-relevant gene and protein data derived from genomics and proteomics. The resulting gene-specific, cell-based assays promise more productive and predictive drug discovery and development, allowing our company to play a significant role in bringing important new medicines to market
